These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3302568)

  • 1. [Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared].
    Laskawi R; Schrader B; Schröder M; Poser R; von der Brelie R
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):242-5. PubMed ID: 3302568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sudden deafness--on the age dependence of therapy results with reference to naftidrofuryl (Dusodril)].
    Koehn W; Nickol HJ
    HNO; 1985 Jan; 33(1):36-9. PubMed ID: 3972647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized double-blind study of therapy of sudden deafness: initial results].
    Desloovere C; Meyer-Breiting E; von Ilberg C
    HNO; 1988 Oct; 36(10):417-22. PubMed ID: 2466024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects and therapy of sudden deafness. Data of a patient sample of the ear, nose, throat clinic of the Wiesbaden City Clinic 1974-1982].
    Zastrow G; Arndt HJ
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):237-41. PubMed ID: 3613774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous obstruction plethysmographic studies on the "borrowing-lending phenomenon" during use of pentoxifyllin and naftidrofuryl].
    Heidrich H; Schartl M
    Verh Dtsch Ges Inn Med; 1978; (84):1403-6. PubMed ID: 741978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy in sensorineural hearing loss in childhood].
    Nickisch A; Heinemann M; Gross M
    Laryngol Rhinol Otol (Stuttg); 1987 Dec; 66(12):664-6. PubMed ID: 3431317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of sudden deafness with the calcium antagonist nimodipine. Results of a comparative study].
    Lenarz T
    Laryngorhinootologie; 1989 Nov; 68(11):634-7. PubMed ID: 2690838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].
    Poser R; Hirche H
    HNO; 1992 Oct; 40(10):396-9. PubMed ID: 1385372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M; Müller R
    J Med; 1987; 18(1):1-15. PubMed ID: 3298515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different forms of drug therapy for progressive sensorineural hearing loss in childhood].
    Nickisch A; Heinemann M; Gross M
    Laryngol Rhinol Otol (Stuttg); 1988 Oct; 67(10):498-500. PubMed ID: 3236983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Course and prognosis in sudden deafness].
    Eichhorn T; Martin G
    HNO; 1984 Aug; 32(8):341-5. PubMed ID: 6207152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences in therapy of acute labyrinthine deafness with low-molecular dextran, pentoxifyllin and nicotinic acid (author's transl)].
    Wissen I; Aziz MY
    Laryngol Rhinol Otol (Stuttg); 1981 Jul; 60(7):361-3. PubMed ID: 6178919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
    Ganança MM; Mangabeira Albernaz PL; Caovilla HH; Ito YI
    Pharmatherapeutica; 1988; 5(3):170-6. PubMed ID: 3283777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
    Denis F; Ketari M; Benzaken J; Renou G
    Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audiological evaluation of twenty patients receiving pentoxifylline and prednisone after sudden deafness: prospective study.
    de Barros FA; Penido NO; Ramos HV; Sanchez ML; Fukuda Y
    Int Tinnitus J; 2003; 9(1):17-22. PubMed ID: 14763324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and electron microscopy study of sudden deafness treatment with the 10% HES 200/0.5 and pentoxifylline combination].
    Leunig A; Szeimies RM; Wilmes E; Gutmann R; Stolz W; Feyh J
    Laryngorhinootologie; 1995 Mar; 74(3):135-40. PubMed ID: 7538765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden sensorineural hearing loss influence of hemodynamical and hemorheological factors on spontaneous recovery and therapy results.
    Desloovere C; Lörz M; Klima A
    Acta Otorhinolaryngol Belg; 1989; 43(1):31-7. PubMed ID: 2477987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic sudden sensorineural hearing loss. What's the appropriate management?].
    Ben Gamra O; Mbarek C; Ben Rejab I; Hariga I; Bhar H; Sghaier L; Zribi S; El Khedim A
    Tunis Med; 2007 Oct; 85(10):839-42. PubMed ID: 18236805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral seizure in naftidrofuryl infusion].
    Maier W; Löhle E
    HNO; 1993 Nov; 41(11):539-41. PubMed ID: 8282580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.